Skip to main content

Table.1 Patient Characteristics for all 2011 U.S. Medicare Beneficiaries diagnosed with Adhesive Capsulitis

From: The epidemiology and etiology of adhesive capsulitis in the U.S. Medicare population

 

All Adhesive Capsulitis Cases

(N = 92,437)

N (%)

Male

33,012 (35.7)

Race

 Asian

2,628 (2.8)

 Black

6,199 (6.7)

 Hispanic

1,620 (1.8)

 Other

2,186 (2.4)

 White

79,804 (86.3)

Dual eligible for Medicaida

10,999 (11.9)

Mean Age (Standard Deviation)

75.7 (7.0)

Age Group

 66–69

24,026 (26.0)

 70–75

29,143 (31.5)

 76–79

14,380 (15.6)

 80–85

15,628 (16.9)

 86 + 

9,260 (10.0)

Region

 Midwest

18,758 (20.3)

 Northeast

19,310 (20.9)

 South

37,440 (40.5)

 West

16,334 (17.7)

Charlson Comorbidity Index (CCI)

 0

24,775 (26.8)

 1

20,391 (22.1)

 2

14,683 (15.9)

 3

11,426 (12.4)

 4 + 

21,162 (22.9)

Frailty Risk Index (FRI)

 0

34,721 (37.6)

 1

30,776 (33.3)

 2

13,593 (14.7)

 3 + 

13,347 (14.4)

Mean Previous Year Medicare Spending (SD)b

$14,176 (23,287)

Comorbidities

 Diabetes, Type 1

3,220 (3.5)

 Diabetes, Type 2

28,611 (31.0)

 Hyperlipidemia

41,106 (44.5)

 Hypertension

53,979 (58.4)

 Thyroid Disorder

16,364 (17.7)

 Rheumatoid arthritis

3,883 (4.2)

 Gout

2,744 (3.0)

 Parkinson’s Disease

1,299 (1.4)

  1. a Beneficiary was fully dual-eligible for Medicare and Medicaid during the month the index shoulder visit occurred
  2. b Total Part A and B payments made by Medicare for the beneficiary over the period of 365-days prior to their index shoulder date